TEL-AVIV, Israel, Sept. 16, 2019 /PRNewswire/ -- Tarsius Pharma, a company developing a breakthrough platform technology for the treatment of blinding ocular diseases, has been awarded a highly competitive HRIZON 2020 Grant from the European Commission worth 2.4 million EUR (~$2.6...